Aleafia Health Inc. AH ALEAF raised $22.7 million via a previously announced bought deal offering.
Under the offering, vertically-integrated Canadian cannabis company issued 27.39 million units of the company, with a price tag of 83 cents for gross proceeds of $22.7 million, counting a partial exercise of the over-allotment option.
Cantor Fitzgerald Canada Corp. was named the lead underwriter and the only book-runner for the offering. The remaining underwriters included Echelon Wealth Partners Inc. and Mackie Research Capital Corp.
Under the offering, each unit is comprised of one company’s share and one-half of one share purchase warrant. Each warrant enables the owner to buy one share at a price of $1.05 in the next two years upon closing the offering.
Warrants issued under the offering should start trading on the Toronto Stock Exchange under the ticker symbol “AH.WT.B.”
Aleafia plans to utilize the collected net proceeds to support various development and working capital projects.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!